Predicate |
Object |
assignee |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_8a8dea6174d15c3859e01e40568b5320 |
classificationCPCAdditional |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K2039-53 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K2039-55577 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K2039-55572 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K2039-55527 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K2039-55538 |
classificationCPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K39-008 |
classificationIPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K39-008 |
filingDate |
2014-05-27-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
inventor |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_934dac6a9288cb058d189fb0576f22ec http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_b791ec86c3854fe98028f2507870a157 http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_c21c3b96db96719f3c704030054a09c5 http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_5ddd2350cf9731ce85454f3d389be4c0 |
publicationDate |
2014-09-11-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
publicationNumber |
US-2014255448-A1 |
titleOfInvention |
Vaccine composition and immunization method |
abstract |
The present invention refers to the recombinant vaccine against canine visceral leishmaniasis containing the recombinant A2 protein and saponin, monophosphoryl lipid A, or aluminum hydroxide plus CpG as an adjuvant, allowing the distinction between vaccinated and infected animals through conventional ELISA or immunofluorescence tests that employ antigens of promastigote forms of Leishmania. |
priorityDate |
2006-07-21-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
type |
http://data.epo.org/linked-data/def/patent/Publication |